Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
126.73
-1.13 (-0.88%)
At close: Jul 26, 2024, 4:00 PM
126.90
+0.17 (0.13%)
After-hours: Jul 26, 2024, 7:59 PM EDT
Novo Nordisk Employees
Novo Nordisk had 64,319 employees as of December 31, 2023. The number of employees increased by 9,134 or 16.55% compared to the previous year.
Employees
64,319
Change (1Y)
9,134
Growth (1Y)
16.55%
Revenue / Employee
$549,547
Profits / Employee
$200,871
Market Cap
575.53B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | 43,258 | 56 | 0.13% |
Dec 31, 2018 | 43,202 | 520 | 1.22% |
Dec 31, 2017 | 42,682 | 711 | 1.69% |
Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
Dec 31, 2015 | 40,638 | -319 | -0.78% |
Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
Dec 31, 2003 | 18,756 | 751 | 4.17% |
Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
Dec 31, 1999 | 11,994 | 345 | 2.96% |
Dec 31, 1998 | 11,649 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
NVO News
- 8 hours ago - Europe's Markets Are Cheap. 4 Stocks to Play. - Barrons
- 14 hours ago - Novo Nordisk's Wegovy wins EU backing for reducing heart risks - CNBC
- 1 day ago - EU regulator backs use of Novo's Wegovy to lower heart risks - Reuters
- 1 day ago - Viking's stock pops as obesity-drug contender drags down Eli Lilly, Novo Nordisk - Market Watch
- 3 days ago - UK Approves Novo Nordisk's Wegovy As First-Of-Its-Kind Treatment To Lower Heart Risks - Forbes
- 3 days ago - Novo Nordisk's Wegovy approved by MHRA in the UK for cardiovascular prevention - Invezz
- 3 days ago - Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment - CNBC
- 3 days ago - Novo Nordisk's Wegovy gets UK approval for lowering heart risks - Reuters